The Jerome Lejeune Foundation has been intensely involved in supporting the development of therapeutic treatments related to the overexpression of the gene
Among the hundreds of genes that are overrepresented in individuals with trisomy 21, a few are highly suspected to be at least partly responsible for cognitive impairment.